Spring Bank Pharmaceuticals, Inc. announced the appointment of Kevin Leach, Ph.D., DABT, as vice president, nonclinical and translational research, a newly created role, and the promotion of Garrett Winslow to the position of general counsel. Dr. Leach prior to joining Spring Bank, he was senior director, nonclinical and translational research, at Retrophin, Inc., in Cambridge, MA. Mr. Winslow, who has served as vice president, legal at Spring Bank since Jan. 2017, will continue to be responsible for corporate legal operations and function as the corporate secretary for Spring Bank.